Spatiotemporal scaling changes in gait in a progressive model of Parkinson's disease
Authors:
Open Access
- 13 December 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 13, 1041934
Abstract
Objective: Gait dysfunction is one of the most difficult motor signs to treat in patients with Parkinson's disease (PD). Understanding its pathophysiology and developing more effective therapies for parkinsonian gait dysfunction will require preclinical studies that can quantitatively and objectively assess the spatial and temporal features of gait.Design: We developed a novel system for measuring volitional, naturalistic gait patterns in non-human primates, and then applied the approach to characterize the progression of parkinsonian gait dysfunction across a sequence of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatments that allowed for intrasubject comparisons across mild, moderate, and severe stages.Results: Parkinsonian gait dysfunction was characterized across treatment levels by a slower stride speed, increased time in both the stance and swing phase of the stride cycle, and decreased cadence that progressively worsened with overall parkinsonian severity. In contrast, decreased stride length occurred most notably in the moderate to severe parkinsonian state.Conclusion: The results suggest that mild parkinsonism in the primate model of PD starts with temporal gait deficits, whereas spatial gait deficits manifest after reaching a more severe parkinsonian state overall. This study provides important context for preclinical studies in non-human primates studying the neurophysiology of and treatments for parkinsonian gait.Keywords
Funding Information
- National Institute of Neurological Disorders and Stroke (F31-NS108625, P50-098573, P50-NS123109, R01-NS037019, R01-NS058945, R01-NS094206, R01-NS117822, R37-NS077657)
This publication has 66 references indexed in Scilit:
- Quantitative assessment of gait and neurochemical correlation in a classical murine model of Parkinson’s diseaseBMC Neuroscience, 2012
- Non-human primate FOG develops with advanced parkinsonism induced by MPTP TreatmentExperimental Neurology, 2012
- Quantitative Normative Gait Data in a Large Cohort of Ambulatory Persons with Parkinson’s DiseasePLOS ONE, 2012
- Normal and pathological gait: what we learn from Parkinson's disease: Figure 1Journal of Neurology, Neurosurgery & Psychiatry, 2012
- External pallidal stimulation improves parkinsonian motor signs and modulates neuronal activity throughout the basal ganglia thalamic networkExperimental Neurology, 2012
- Modeling Parkinson's Disease in Primates: The MPTP ModelCold Spring Harbor Perspectives in Medicine, 2011
- Automated quantitative gait analysis in animal models of movement disordersBMC Neuroscience, 2010
- Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson diseaseJournal of Clinical Investigation, 2010
- Pallidal stimulation that improves parkinsonian motor symptoms also modulates neuronal firing patterns in primary motor cortex in the MPTP-treated monkeyExperimental Neurology, 2009
- The pathogenesis of gait hypokinesia in Parkinson's diseaseBrain, 1994